MDPiHP Crystal Overview

• IUPAC Name: 1-(3,4-methylenedioxyphenyl)-2-(pyrrolidin-1-yl)-propan-1-one hydrochloride
• Commercial Name: MDPiHP Crystal
• Chemical Formula: C12H15NO2·HCl
• Molar Mass: 227.72 g/mol
• Boiling Point: Not readily available (MDPiHP is a crystalline solid that typically decomposes before boiling)
• Melting Point: Approximately 146–150°C (decomposes before the melting point is reached)
• Density: Not readily available; typical density for similar crystalline compounds is approximately 1.1–1.3 g/cm³
• Storage Requirements:
  • MDPiHP crystals should be stored in a cool, dry, and dark place to maintain its stability and prevent degradation.
  • Store in an airtight container, preferably vacuum-sealed, to protect the compound from moisture and air.
  • Ideal storage temperature is between 4°C and 8°C. Prolonged exposure to higher temperatures or sunlight may degrade the compound.
  • Avoid contamination by handling with clean, dry equipment, and prevent contact with reactive chemicals.
• Purity: 99.9% (research-grade, as confirmed by Certificate of Analysis)
• Reactivity:
  • MDPiHP is stable when stored correctly under controlled conditions. However, it can react with strong acids, bases, or oxidizing agents, leading to chemical decomposition or unwanted reactions.
  • The compound is sensitive to heat, moisture, and prolonged exposure to air, which can reduce its potency or cause chemical instability.
  • Always handle MDPiHP in a controlled environment to avoid accidental exposure to incompatible materials.
• Safety Information:
  • General Safety: MDPiHP is a stimulant belonging to the substituted cathinone class, and it is chemically similar to other compounds like methamphetamine or MDMA. It is known for its euphoric and stimulating effects but should be used with caution due to the lack of comprehensive data regarding its long-term safety and effects.
  • Handling: When working with MDPiHP, always wear the appropriate personal protective equipment (PPE), including gloves, goggles, and a lab coat. Work in a well-ventilated area or under a fume hood to minimize inhalation of particles or vapors.
  • Toxicity: While there is limited toxicity data for MDPiHP, like other stimulants, it may cause cardiovascular effects (increased heart rate, elevated blood pressure), anxiety, and other psychological or physiological reactions, especially with high doses or prolonged use. Always follow dosage guidelines to minimize adverse effects.
  • First Aid Measures:
    • Skin contact: If MDPiHP comes into contact with the skin, wash immediately with soap and water. If irritation or an allergic reaction occurs, seek medical attention.
    • Eye contact: In case of eye contact, rinse the eyes thoroughly with water for at least 15 minutes. If irritation persists or vision changes occur, seek medical attention.
    • Inhalation: If inhaled, move to fresh air immediately. If symptoms such as dizziness, shortness of breath, or chest tightness appear, seek medical help.
    • Ingestion: In case of accidental ingestion, seek medical assistance immediately. Do not induce vomiting unless directed by a healthcare professional.

This MDPiHP Crystal overview outlines the essential chemical properties and safety measures required for handling the compound. As a stimulant with psychoactive effects, it is crucial to treat MDPiHP with caution in a controlled research environment. By following recommended storage guidelines, safety protocols, and handling procedures, researchers can safely work with MDPiHP while minimizing risks.